Partners - Parker Institute for Cancer Immunotherapy

Create innovative clinical trial solutions for biopharma companies

Develop curative cell therapies, with a focus on solid tumors

Analyze CAR T therapies to improve effectiveness against solid tumors

Unlock the promise of cell and immunotherapy for brain tumors

Collect and analyze patient samples to understand autoimmune side effects following checkpoint therapy

Accelerate treatment options for pancreatic cancer patients

Leading the pursuit of novel medicines by revolutionizing how they’re made, funded and scaled

Better understand the microbiome’s effect on cancer immunotherapy

Develop a new class of biologics

Use immune insights to help deliver life changing therapies to those who need them most

Conduct innovative clinical trials using novel cell therapy treatments

Understand, predict and prevent insulin-dependent diabetes following checkpoint therapy

Working together to support the next generation of cancer research heroes

Support development of next-generation T-cell immunotherapies

Create universal CAR-T therapies to treat multiple cancer types

Directory